← PREVIOUS POSTJapanese Patent Further Extends Coverage for Glycotest’s Serious Liver Disease Diagnostic Technology in Asia. NEXT POST →Glycotest’s Patent Portfolio Covering Important Asian Liver Disease Diagnostic Market Grows through Grant of Hong Kong Patent.